11/19/2025
As more people receive genetic testing after a cancer diagnosis, newer variants have been identified that increase risk of developing cancer.
A study led by the U-M researchers finds that patients with ATM, CHEK2 or PALB2 variants of genes face no extra risk of dying from their pancreatic cancer.
Learn more: https://michmed.org/zgwex